Yoshimura S, Tsurumi Y, Takase S, Okuhara M
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Ibaraki, Japan.
J Antibiot (Tokyo). 1995 Oct;48(10):1073-5. doi: 10.7164/antibiotics.48.1073.
The structures of WS75624 A and B, novel endothelin converting enzyme inhibitors, were determined to be 1 and 2A, respectively, by a combination of chemical evidence and a series of 2D NMR spectral analyses.
新型内皮素转化酶抑制剂WS75624 A和B的结构,通过化学证据与一系列二维核磁共振光谱分析相结合的方法,分别确定为1和2A。